针对性多层睡眠手术对严重阻塞性睡眠呼吸暂停患者耐性高血压的影响
Ahmed Bahgat1, Mostafa Elwany2, Claudio Vicini3
1Department of Otorhinolaryngology-Head & Neck Surgery, Alexandria University, Egypt.
The Journal of international medical research
|September 29, 2025
概括
多层睡眠手术显著降低了耐性高血压和严重阻塞性睡眠呼吸暂停 (OSA) 的患者的血压. 这种手术方法为那些无法忍受持续正气道压力治疗的人提供了有效的替代方案.
科学领域:
- 心血管医学 心血管医学
- 睡眠医学 睡眠医学
- 手术创新 在外科创新.
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是心血管疾病的重要危险因素,特别是耐性高血压.
- 持续正气道压力 (CPAP) 治疗是一种常见的治疗方法,但患者的服从性和耐受性可能具有挑战性.
- 多层次睡眠手术为特定患者群体的OSA管理提供了潜在的替代方案.
研究的目的:
- 评估多层睡眠手术在降低血压水平方面的有效性.
- 评估这种手术干预对抗性高血压和严重的OSA患者的影响.
- 为了确定手术治疗是否可以改善非CPAP耐受性患者的心血管结果.
主要方法:
- 进行了一项双中心的回顾性观察性研究.
- 50名患有严重的OSA和抗性高血压的患者接受了多层次的有针对性的睡眠手术.
- 手术前和手术后 (6个月) 进行了测谎仪和血压测量.
主要成果:
- 平均呼吸暂停-呼吸暂停指数 (AHI) 从44.98降至22.16 (P < 0.005) 的显著降低.
- 平均静缩血压从150 mmHg下降到124 mmHg (P < 0.001). 这是一个非常明显的变化.
- 平均压力从94mmHg降至80mmHg (P<0.001),其中40%的人停止服用抗高血压药物.
结论:
- 多层睡眠手术是改善血压控制的有效干预措施.
- 这种手术方法对抗性高血压和严重的OSA患者有希望.
- 这项研究是首次评估这种患者群体中抗性高血压的多层次手术.
相关概念视频
Sleep Apnea
481
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
481
Management of Insomnia
542
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
542
Sedatives and Hypnotics: Overview
1.4K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.4K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
518
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
518
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
589
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
589


